| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/17/2003 | WO2003057213A2 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057212A1 Polyamide derivatives possessing antibacterial, antifungal or antitumor activity |
| 07/17/2003 | WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003008410A3 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 07/17/2003 | WO2002006280A3 INHIBITORS OF FACTOR Xa |
| 07/17/2003 | US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate |
| 07/17/2003 | US20030134889 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/17/2003 | US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 07/17/2003 | US20030134886 Pharmaceutically active compounds |
| 07/17/2003 | US20030134853 Tetrazolyl- and carbamidosulfonyl-substituted 2-phenyl-1-cycloalkyl -benzimidazoles or -imidazo(4,5b)pyridines that inhibit the RNA-dependent RNA polymerase encoded by Hepatitis C |
| 07/17/2003 | US20030134850 Hydrazinyl and nitrogen oxide pyrazoles |
| 07/17/2003 | US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators |
| 07/17/2003 | US20030134838 Treatment of illnesses in which beta -amyloid modulators have a therapeutic benefit, the use thereof for preparing a pharmaceutical composition with the abovementioned properties, and processes for the preparation thereof. |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 07/17/2003 | CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | CA2471885A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | CA2471880A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | CA2471754A1 Androgen receptor antagonist |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1327631A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326849A1 Benzodiazepine derivatives as inhibitors of gamma secretase |
| 07/16/2003 | EP1326843A1 Pyrazole derivatives for the treatment of viral diseases |
| 07/16/2003 | EP1326830A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 07/16/2003 | EP1326829A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
| 07/16/2003 | EP1326643A2 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1261587B1 Stilbene derivatives, their preparation and their use as antiviral agents |
| 07/16/2003 | EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114598C Aromatic compounds and pharmaceutical compositions containing them |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/15/2003 | US6593477 Synthesis of 3-acylaminopyrazoles |
| 07/15/2003 | US6593474 Adrenergic blocking agents |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593356 The present invention relates to the synthesis of a new class of indeno(1,2-c)pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and the |
| 07/15/2003 | US6593355 Benzimidazoles with antithrombotic activity |
| 07/15/2003 | US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases |
| 07/15/2003 | US6593328 Pesticides |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593323 Benzimidazole compounds and drugs containing the same |
| 07/15/2003 | US6593013 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 07/10/2003 | WO2003055877A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 07/10/2003 | WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003055863A1 Novel alkansulfonamides as endothelin antagonists |
| 07/10/2003 | WO2003055860A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 07/10/2003 | WO2003055522A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/10/2003 | WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055491A1 Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 07/10/2003 | WO2003055489A1 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003022274A3 2-aroylimidazole compounds for treating cancer |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 07/10/2003 | WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130328 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/10/2003 | US20030130325 Substituted tryptophan derivatives |
| 07/10/2003 | US20030130289 Inhibitors of glycogen synthase kinase 3 |
| 07/10/2003 | US20030130285 Controlling cell differentiation, cell proliferation |
| 07/10/2003 | US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2003 | US20030130281 DPP IV inhibitors |
| 07/10/2003 | US20030130280 Analyzing, prevention blood phosphorylation |
| 07/10/2003 | US20030130278 Alkynylated fused ring pyrimidine compounds |
| 07/10/2003 | US20030130275 Sulfonamide compounds with pharmaceutical activity |
| 07/10/2003 | US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors |
| 07/10/2003 | US20030130234 Novel indolinones and uses thereof |
| 07/10/2003 | US20030130203 Sleep disorders |
| 07/10/2003 | US20030130125 Pesticides; herbicides |
| 07/10/2003 | US20030130122 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 07/09/2003 | EP1325916A1 Piperazinyl-substituted phenyl pyrimidine derivatives useful in the treatment or prevention of disorders of the central nervous system |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1325011A2 Methods and compounds for treating proliferative diseases |
| 07/09/2003 | EP1325006A2 Heterocyclic compounds as ligands of the gaba a? receptor |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324996A2 Substituted aryl ketones |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 07/09/2003 | EP1324983A1 Process for preparing distamycin derivatives |
| 07/09/2003 | EP0973768B1 Azole compounds, their production and their use |
| 07/09/2003 | EP0937067B1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors |
| 07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 07/09/2003 | EP0912557B1 Oxindole derivatives |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | CN1429231A Ligand and complex for catalytically bleaching substate |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/09/2003 | CN1113874C Benzocycloalkylazolethione derivatives |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |